Literature DB >> 25882637

Canine heat shock protein 27 promotes proliferation, migration, and doxorubicin resistance in the canine cell line DTK-F.

An-Ci Lin1, Cheng-Wei Liao1, Sui-Wen Lin2, Chien-Yi Huang3, Chian-Jiun Liou4, Yu-Shen Lai5.   

Abstract

Canine mammary tumors (CMTs) are the most common type of tumors in female dogs. Heat shock proteins are highly expressed in many cancers and are involved in tumor progression and chemoresistance in CMTs; however, the biological role of canine heat shock protein 27 (cHSP27) in CMTs has not been thoroughly characterized. This study investigated the roles of cHSP27 in cell growth, migration, anchorage, and resistance to doxorubicin (DOX) using DTK-F cells, a CMT cell line that does not express cHSP27. DTK-F cells were transfected with cHSP27 and stable overexpression was established. A mouse monoclonal antibody against cHSP27 was also produced. The biological functions of cHSP27 in DTK-F cells were then evaluated using a variety of assays. Overexpression of cHSP27 was associated with increased cell proliferation, clone formation, migration, and decreased DOX sensitivity. In conclusion, these data provide evidence that cHSP27 overexpression can promote anchorage-independent growth, migration, and increased DOX resistance in CMT cells.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Canine; Drug resistance; Heat shock protein 27; Mammary tumors; Oncology

Mesh:

Substances:

Year:  2015        PMID: 25882637     DOI: 10.1016/j.tvjl.2015.02.023

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  2 in total

1.  Circulating level of heat shock protein 27 is elevated in dogs with mammary tumors.

Authors:  Rancy Birdi; B V Sunil Kumar; Kuldip Gupta; Neeraj Kashyap; Ashwani Kumar
Journal:  3 Biotech       Date:  2019-05-22       Impact factor: 2.406

2.  Voluntary Running Aids to Maintain High Body Temperature in Rats Bred for High Aerobic Capacity.

Authors:  Sira M Karvinen; Mika Silvennoinen; Hongqiang Ma; Timo Törmäkangas; Timo Rantalainen; Rita Rinnankoski-Tuikka; Sanna Lensu; Lauren G Koch; Steven L Britton; Heikki Kainulainen
Journal:  Front Physiol       Date:  2016-07-25       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.